[Translation] A randomized, double-blind, placebo-controlled dose-finding and tolerability study of levothyroxine hydrochloride tablets (LS001) in the treatment of early and mid-stage Parkinson's disease
主要目的:评价LS001在早、中期帕金森病患者中的安全性和耐受性
次要目的:评价LS001治疗早、中期帕金森病的初步有效性以及在早、中期帕金森病群体药代动力学特征
[Translation] Main objective: To evaluate the safety and tolerability of LS001 in patients with early and mid-stage Parkinson's disease
Secondary objective: To evaluate the preliminary efficacy of LS001 in the treatment of early-stage and mid-stage Parkinson's disease and the population pharmacokinetic characteristics of early-stage and mid-stage Parkinson's disease